what drugs are glp 1 agonists comparison of Table 1 from Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists Drug Class Review GLP-1 Receptor Agonists and Research

February 3, 2026: Man Sues Ozempic, Claims the Injectable Semaglutide Caused Him to Lose Sight A man from Ohio has filed a legal claim against Ozempics manufacturer, Novo Nordisk, alleging that he developed NAION after taking Ozempic as prescribed

GLP-1 RAs, such as semaglutide and tirzepatide, may also help improve metabolic health in patients with PCOS by promoting weight loss, improving insulin sensitivity, and reducing blood glucose levels ( 4 , 6 , 14 )

Two deals in quick succession make it pretty clear that Pfizer is building an aggressive metabolic strategy

1,2 Effective post-overdose interventions remain limited: medications for opioid use disorder reduce repeat overdose risk substantially but reach only a small minority of survivors, and no widely used pharmacotherapy addresses the broader range of substances involved in overdose events

Increasing investments in metabolic disease research, expanding clinical development programs, and continuous advancements in small-molecule drug discovery technologies are further accelerating market growth

By Payer Type, Private and Self-Pay Segment Accounts for 70% Market Share Private insurance and self-pay arrangements are projected to contribute 70% of the market in 2025, representing patients who access treatment through commercial health insurance or direct cash payment